[Clinical significance and therapeutic application of atrial natriuretic peptides].
Hirata
Y
Y
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000096:biosynthesis* / Q000097:blood / Q000627:therapeutic use; D006020:Glycopeptides / Q000627:therapeutic use; D006325:Heart Atria / Q000378:metabolism; D006333:Heart Failure / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D017461:Receptors, Atrial Natriuretic Factor; D011956:Receptors, Cell Surface / Q000378:metabolism; D015244:Thiorphan / Q000031:analogs & derivatives / Q000627:therapeutic use
D006020:Glycopeptides; D011956:Receptors, Cell Surface; C049331:racecadotril; D009320:Atrial Natriuretic Factor; D015244:Thiorphan; D017461:Receptors, Atrial Natriuretic Factor; C008890:phosphoramidon